Sugammadex is very well tolerated with no significant cardiovascular or hemodynamic adverse events.26 Dysgeusia (metallic or bitter taste) was the most common adverse event, but this was primarily seen at doses ≥32 mg/kg; there were only a few reports of dysgeusia in surgical patients receiving the drug. Age, gender, race, and ethnicity do not appear to influence the safety of sugammadex.27